Suppr超能文献

用于水溶性药物缓释的薄膜包衣骨架型小片。

Film-coated matrix mini-tablets for the extended release of a water-soluble drug.

作者信息

Mohamed Faiezah A A, Roberts Matthew, Seton Linda, Ford James L, Levina Marina, Rajabi-Siahboomi Ali R

机构信息

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University , Liverpool , UK and.

出版信息

Drug Dev Ind Pharm. 2015 Apr;41(4):623-30. doi: 10.3109/03639045.2014.891128. Epub 2014 Feb 24.

Abstract

Extended release (ER) of water-soluble drugs from hydroxypropylmethylcellulose (HPMC) matrix mini-tablets (mini-matrices) is difficult to achieve due to the large surface area to volume ratio of the mini matrices. Therefore, the aims of this study were to control the release of a water-soluble drug (theophylline) from mini-matrices by applying ER ethylcellulose film coating (Surelease®), and to assess the effects of Surelease®:pore former (Opadry®) ratio and coating load on release rates. Mini-matrices containing 40%w/w HPMC K100M CR were coated with 100:0, 85:15, 80:20, 75:25 or 70:30 Surelease®:Opadry® to different coating weight gains (6-20%). Non-matrix mini-tablets were also produced and coated with 80:20 Surelease®:Opadry® to different coating weight gains. At low coating weight gains, nonmatrix mini-tablets released the entire drug within 0.5 h, while at high coating weight gains only a very small amount (<5%) of drug was released after 12 h. The gel formation of HPMC prevented disintegration of mini-matrices at low coating weight gains but contributed to rupture of the film even at high coating weight gains. As a result, drug release from mini-matrices was slower than that from nonmatrix mini-tablets at low coating weight gains, yet faster at high coating weight gains. An increase in the lag time of drug release from mini-matrices was observed as the concentration of Opadry® reduced or the coating weight gain increased. This study has demonstrated the possibility of extending the release of a water-soluble drug from HPMC mini-matrices by applying ER film coating with appropriate levels of pore former and coating weight gains to tailor the release rate.

摘要

由于羟丙基甲基纤维素(HPMC)基质微型片(微型基质)的表面积与体积比很大,因此很难实现水溶性药物从其中的缓释。因此,本研究的目的是通过应用乙基纤维素缓释包衣(Surelease®)来控制水溶性药物(茶碱)从微型基质中的释放,并评估Surelease®与致孔剂(欧巴代®)的比例以及包衣载量对释放速率的影响。含有40%w/w HPMC K100M CR的微型基质用100:0、85:15、80:20、75:25或70:30的Surelease®:欧巴代®进行包衣,达到不同的增重(6%-20%)。还制备了非基质微型片,并用80:20的Surelease®:欧巴代®进行包衣,达到不同的增重。在低包衣增重时,非基质微型片在0.5小时内释放出全部药物,而在高包衣增重时,12小时后仅释放出极少量(<5%)的药物。HPMC的凝胶形成在低包衣增重时可防止微型基质崩解,但即使在高包衣增重时也会导致薄膜破裂。结果,在低包衣增重时,微型基质中的药物释放比非基质微型片慢,但在高包衣增重时则更快。随着欧巴代®浓度降低或包衣增重增加,微型基质中药物释放的滞后时间延长。本研究证明了通过应用含有适当致孔剂水平和包衣增重的缓释包衣来调整释放速率,从而延长水溶性药物从HPMC微型基质中释放的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验